0001393905-17-000386.txt : 20171205 0001393905-17-000386.hdr.sgml : 20171205 20171205085909 ACCESSION NUMBER: 0001393905-17-000386 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20171205 DATE AS OF CHANGE: 20171205 EFFECTIVENESS DATE: 20171205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300045 FILM NUMBER: 171238737 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 D 1 primary_doc.xml X0708 D LIVE 0001533743 Processa Pharmaceuticals, Inc. 7380 COCA COLA DRIVE SUITE 106 HANOVER MD MARYLAND 21076 443-776-3133 DELAWARE Heatwurx, Inc. Corporation true David Young 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Director Patrick Lin 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Director Justin York 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Director Virgil Thompson 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Director Pharmaceuticals No Revenues 06c false 2017-10-04 false true true Convertible debt false 10000 Boustead Securities, LLC 141391 None None 6 Venture Suite 325 Irvine CA CALIFORNIA 92618 All States false 2580000 2580000 0 false 23 154800 0 0 false Processa Pharmaceuticals, Inc. /s/ David Young David Young Chief Executive Officer 2017-12-04